Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
267.2 SEK | -1.84% | -1.33% | +0.07% |
Mar. 14 | Certain Shares of Swedish Orphan Biovitrum AB are subject to a Lock-Up Agreement Ending on 14-MAR-2024. | CI |
Feb. 13 | Sobi to Expand in South Korea via Rare Disease JV with Handok | MT |
Sales 2023 | 22.12B 2.07B | Sales 2024 * | 23.95B 2.24B | Capitalization | 90.78B 8.48B |
---|---|---|---|---|---|
Net income 2023 | 2.41B 225M | Net income 2024 * | 3.6B 337M | EV / Sales 2023 | 4.97 x |
Net Debt 2023 | 19.26B 1.8B | Net Debt 2024 * | 14.77B 1.38B | EV / Sales 2024 * | 4.41 x |
P/E ratio 2023 |
36.1
x | P/E ratio 2024 * |
25.5
x | Employees | 1,772 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 52.21% |
Latest transcript on Swedish Orphan Biovitrum AB
1 day | -1.84% | ||
1 week | -1.33% | ||
Current month | +4.95% | ||
1 month | +5.45% | ||
6 months | +19.82% | ||
Current year | +0.07% |
Managers | Title | Age | Since |
---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 59 | 17-05-21 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 57 | 18-07-19 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sven Ullman
BRD | Director/Board Member | 68 | 20-12-31 |
Matthew Gantz
BRD | Director/Board Member | 59 | 12-04-25 |
Annette Clancy
CHM | Chairman | 70 | 14-05-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 222 M€ | +8.28% | ||
0.90% | 5 M€ | +12.89% | ||
0.69% | 159 M€ | +9.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 267.2 | -1.84% | 197,348 |
24-03-27 | 272.2 | +1.64% | 328,104 |
24-03-26 | 267.8 | -0.15% | 540,104 |
24-03-25 | 268.2 | -0.37% | 311,572 |
24-03-22 | 269.2 | -0.59% | 387,948 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.07% | 8.5B | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
-11.81% | 7.82B |